{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:21:11Z","timestamp":1790835671854,"version":"4.1.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Systemic sclerosis (SSc)-associated heart involvement (SHI) is a significant cause of both morbidity and mortality in individuals with SSc. SHI can take many different forms, and likely is a spectrum of fibroinflammatory cardiac disease. Presenting features include arrhythmia, ventricular systolic or diastolic dysfunction, pericardial disease, and exercise intolerance. Risk of sudden cardiac death in SSc is likely 10\u201330-fold greater than general population estimates. In this review, we explore what is known about the pathogenesis of SHI, its prevention and management, and discuss available strategies for screening for SHI in light of new recommendations for the routine screening of SHI in all SSc patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>We describe the spectrum, clinical features, and pathogenesis of SHI. Furthermore, we review the new recommendations for screening for SHI in individuals with SSc.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>There is a large, under-recognized burden of SHI in people living with SSc, which likely contributes to the significant increase in sudden cardiac death observed in SSc. However, a broad-based screening approach, including asymptomatic, low-risk patients should be viewed with caution given the lack of evidence-based treatments and interventions for SHI particularly in this group.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001038","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:00:10Z","timestamp":1723215610000},"page":"393-400","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Heart involvement in systemic sclerosis: emerging concepts"],"prefix":"10.1097","volume":"36","author":[{"given":"Jessica L.","family":"Fairley","sequence":"first","affiliation":[{"name":"The University of Melbourne"},{"name":"St. Vincent's Hospital Melbourne, Melbourne, Victoria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ross","sequence":"additional","affiliation":[{"name":"The University of Melbourne"},{"name":"St. Vincent's Hospital Melbourne, Melbourne, Victoria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[{"name":"The University of Melbourne"},{"name":"St. Vincent's Hospital Melbourne, Melbourne, Victoria"},{"name":"The University of Sydney School of Public Health, Sydney"},{"name":"Royal Prince Alfred Hospital Sydney"},{"name":"SydneyMSK Research Flagship Centre, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/23971983211053246","article-title":"Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF\/HFA definition","volume":"7","author":"Bruni","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"152229","DOI":"10.1016\/j.semarthrit.2023.152229","article-title":"Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: a systematic review and meta-analysis","volume":"62","author":"Fairley","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D\u2019Angelo","year":"1969","journal-title":"Am J Med"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1093\/rheumatology\/keac065","article-title":"Myocardial fibrosis and arrhythmic burden in systemic sclerosis","volume":"61","author":"Ross","year":"2022","journal-title":"Rheumatology (Oxford, England)"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.semarthrit.2020.10.016","article-title":"Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review","volume":"51","author":"Ross","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/imj.16233","article-title":"Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease","volume":"53","author":"Fairley","year":"2023","journal-title":"Intern Med J"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"152443","DOI":"10.1016\/j.semarthrit.2024.152443","article-title":"Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis","volume":"66","author":"Fairley","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"R13-20250526","first-page":"1986","article-title":"The clinical implications of left ventricular diastolic dysfunction in systemic sclerosis","volume":"40","author":"Ross","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"152033","DOI":"10.1016\/j.semarthrit.2022.152033","article-title":"Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry","volume":"55","author":"Gonzalez Garcia","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"152137","DOI":"10.1016\/j.semarthrit.2022.152137","article-title":"Disease specific determinants of cardiopulmonary fitness in systemic sclerosis","volume":"58","author":"Ross","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3899\/jrheum.2023-0801","article-title":"Contribution of left ventricular diastolic dysfunction to survival and breathlessness in systemic sclerosis-associated interstitial lung disease","volume":"51","author":"Fairley","year":"2024","journal-title":"J Rheumatol"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/art.23463","article-title":"Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients","volume":"58","author":"Meune","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3899\/jrheum.201005","article-title":"Increased risk of valvular heart disease in systemic sclerosis: an underrecognized cardiac complication","volume":"48","author":"Kurmann","year":"2021","journal-title":"J Rheumatol"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0025-6196(12)61286-5","article-title":"Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error","volume":"64","author":"Hauck","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1871528114666150916112551","article-title":"Cardiovascular magnetic resonance imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis","volume":"14","author":"Mavrogeni","year":"2015","journal-title":"Inflamm Allergy Drug Targets"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"e013405","DOI":"10.1161\/JAHA.119.013405","article-title":"Cardiovascular manifestations of systemic sclerosis: a Danish Nationwide Cohort Study","volume":"8","author":"Butt","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/rheumatology\/kez658","article-title":"Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis","volume":"59","author":"De Luca","year":"2020","journal-title":"Rheumatology (Oxford, England)"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00259-022-06081-4","article-title":"Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT","volume":"50","author":"Treutlein","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1093\/rheumatology\/keac674","article-title":"Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study","volume":"62","author":"Ninagawa","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"(5 Suppl 62)","key":"R26-20250526","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/25.2.158","article-title":"Reversible myocardial perfusion defects during cold challenge in scleroderma","volume":"25","author":"Long","year":"1986","journal-title":"Br J Rheumatol"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/rheumatology\/keu350","article-title":"Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography","volume":"54","author":"Rodriguez-Reyna","year":"2015","journal-title":"Rheumatology (Oxford, England)"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"e0244282","DOI":"10.1371\/journal.pone.0244282","article-title":"Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: a cardiovascular magnetic resonance study with cold pressor test","volume":"15","author":"Galea","year":"2020","journal-title":"PLoS One"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ehjci\/jeae001","article-title":"Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension","volume":"25","author":"Vos","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1093\/rheumatology\/keac098","article-title":"Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation","volume":"61","author":"De Luca","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/annrheumdis-2011-201176","article-title":"Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis","volume":"71","author":"Ngian","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10067-006-0211-8","article-title":"Acute myocardial infarction in systemic sclerosis patients: a case series","volume":"26","author":"Derk","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/annrheumdis-2022-eular.4184","article-title":"OP0159 Increase risk for coronary artery disease and myocardial infarction in scleroderma-a national inpatient sample analysis","volume":"81","author":"Raj","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"(8_Supplement)","key":"R35-20250526","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/S0735-1097(23)03385-5","article-title":"Systolic heart failure and minoca in patients with systemic sclerosis: a diagnostic dilemma","volume":"81","author":"Mohammad","year":"2023","journal-title":"JACC"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"152363","DOI":"10.1016\/j.semarthrit.2024.152363","article-title":"Proximal weakness and creatine kinase elevation in systemic sclerosis: clinical correlates, prognosis and functional implications","volume":"65","author":"Fairley","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/art.1780240506","article-title":"Association of myositis and myocarditis in progressive systemic sclerosis","volume":"24","author":"West","year":"1981","journal-title":"Arthritis Rheum"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"e001689","DOI":"10.1136\/rmdopen-2021-001689","article-title":"Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers","volume":"7","author":"Dumitru","year":"2021","journal-title":"RMD open"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2397198318762888","article-title":"Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis","volume":"3","author":"Lee","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.41308","article-title":"Cardiac intravoxel incoherent motion diffusion-weighted magnetic resonance imaging with T1 mapping to assess myocardial perfusion and fibrosis in systemic sclerosis: association with cardiac events from a prospective cohort study","volume":"72","author":"Terrier","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jjcc.2023.03.003","article-title":"Native T1 mapping in early diffuse and limited systemic sclerosis, and its association with diastolic function","volume":"82","author":"Purevsuren","year":"2023","journal-title":"J Cardiol"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/rheumatology\/kez494","article-title":"Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)","volume":"59","author":"Mavrogeni","year":"2020","journal-title":"Rheumatology (Oxford, England)"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/jcm13010089","article-title":"Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis","volume":"13","author":"Gargani","year":"2023","journal-title":"J Clin Med"},{"key":"R45-20250526","first-page":"31","article-title":"Prognostic role of ventricular ectopic beats in systemic sclerosis","volume":"1","author":"De Luca","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/rheumatology\/key430","article-title":"Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP","volume":"58","author":"Bissell","year":"2019","journal-title":"Rheumatology (Oxford, England)"},{"key":"R47-20250526","first-page":"1933","article-title":"Troponin elevation independently associates with mortality in systemic sclerosis","volume":"40","author":"Paik","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1038\/s41467-023-41117-9","article-title":"Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis","volume":"14","author":"Ortega-Ferreira","year":"2023","journal-title":"Nat Commun"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijcard.2017.08.072","article-title":"Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - relationship with biochemical and echocardiography parameters","volume":"249","author":"Hromadka","year":"2017","journal-title":"Int J Cardiol"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.38241","article-title":"Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development","volume":"66","author":"Lambrecht","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/diagnostics11112165","article-title":"Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates","volume":"11","author":"Caforio","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/diagnostics11061064","article-title":"Quantification of antifibrillarin (anti-U3 RNP) antibodies: a new insight for patients with systemic sclerosis","volume":"11","author":"Benyamine","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/23971983231163413","article-title":"Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation\/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment","volume":"8","author":"Bruni","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/acr.24053","article-title":"Can patient-reported symptoms be used to measure disease activity in systemic sclerosis?","volume":"72","author":"Ross","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.pec.2022.03.022","article-title":"Effects of educational intervention on mortality and patient-reported outcomes in individuals with heart failure: a randomized controlled trial","volume":"105","author":"Hwang","year":"2022","journal-title":"Patient Educ Couns"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar3876","article-title":"N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study","volume":"14","author":"Thakkar","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00296-018-4004-6","article-title":"Can cardiovascular magnetic resonance prompt early cardiovascular\/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives","volume":"38","author":"Mavrogeni","year":"2018","journal-title":"Rheumatol Int"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/03009740903493741","article-title":"Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone","volume":"39","author":"Stack","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/annrheumdis-2022-eular.905","article-title":"AB0660. Long-term effect of combination therapy with rituximab and mycophenolic acid on cardiac manifestations, pulmonary function and skin fibrosis in systemic sclerosis","volume":"81","author":"Adjailia","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"152126","DOI":"10.1016\/j.semarthrit.2022.152126","article-title":"Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: an update","volume":"58","author":"Mavrogeni","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/annrheumdis-2019-215486","article-title":"Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study","volume":"78","author":"Valentini","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials","volume":"64","author":"Kusumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3899\/jrheum.100480","article-title":"Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis","volume":"38","author":"Bernardo","year":"2011","journal-title":"J Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:18:52Z","timestamp":1748294332000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001038","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]}}}